SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-039756
Filing Date
2022-07-18
Accepted
2022-07-15 20:28:05
Documents
14
Period of Report
2022-07-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea162961-8k_inmedpharma.htm   iXBRL 8-K 25305
2 AMENDMENT DATED JULY 11, 2022 TO ERIC ADAMS' EMPLOYMENT AGREEMENT DATED 1 MARCH ea162961ex10-1_inmedpharma.htm EX-10.1 9580
3 GRAPHIC ex10-1_001.jpg GRAPHIC 4989
  Complete submission text file 0001213900-22-039756.txt   216873

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE inm-20220711_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inm-20220711_pre.xml EX-101.PRE 22364
6 XBRL SCHEMA FILE inm-20220711.xsd EX-101.SCH 2965
8 EXTRACTED XBRL INSTANCE DOCUMENT ea162961-8k_inmedpharma_htm.xml XML 3618
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221087972
SIC: 2834 Pharmaceutical Preparations